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The neuroprotection induced byHypericum brasiliense Choisy extract (HBE) and its main active polyphenol compound quercetin,
against Crotalus durissus terrificus (Cdt) venom and crotoxin and crotamine, was enquired at both central and peripheral mammal
nervous system. Cdt venom (10𝜇g/mL) or crotoxin (1 𝜇g/mL) incubated at mouse phrenic nerve-diaphragm preparation (PND)
induced an irreversible and complete neuromuscular blockade, respectively. Crotamine (1𝜇g/mL) only induced an increase of
muscle strength at PND preparations. At mouse brain slices, Cdt venom (1, 5, and 10 𝜇g/mL) decreased cell viability. HBE
(100𝜇g/mL) inhibited significantly the facilitatory action of crotamine (1 𝜇g/mL) andwas partially active against the neuromuscular
blockade of crotoxin (1𝜇g/mL) (data not shown). Quercetin (10𝜇g/mL) mimicked the neuromuscular protection of HBE
(100𝜇g/mL), by inhibiting almost completely the neurotoxic effect induced by crotoxin (1𝜇g/mL) and crotamine (1𝜇g/mL). HBE
(100𝜇g/mL) and quercetin (10𝜇g/mL) also increased cell viability in mice brain slices. Quercetin (10𝜇g/mL) was more effective
than HBE (100𝜇g/mL) in counteracting the cell lysis induced by Cdt venom (1 and 10𝜇g/mL, resp.). These results and a further
phytochemical and toxicological investigations could open new perspectives towards therapeutic use of Hypericum brasiliense
standardized extract and quercetin, especially to counteract the neurotoxic effect induced by snake neurotoxic venoms.
1. Introduction
An estimated 5.4-5.5 million people are bitten by snakes
each year, resulting in about 400.000 amputations and about
125.000 deaths [1, 2]. The problem of human suffering by
snake bite is actually so relevant that WHO has included it
in the list of neglected tropical diseases in April, 2009 [3].
Snake venoms embody a complex mixture of toxic
enzymes and proteins, such as myotoxins, neurotoxins, cyto-
toxins, hemorrhagic metalloproteases, clotting serinepro-
teases, and others [4]. Among all snake venoms, the crotalic
is one of themost neurotoxic, in which systemic effects reside
primarily in the peripheral neurotoxicity. However, when
injected directly on CNS of mammals it can induce convul-
sion anddeath [5]. Among other symptoms, the neurotoxicity
induced by Crotalus poisoning in both central and peripheral
nervous system ismainly related to the presence in the venom
of the toxins crotoxin [6] and crotamine [7]. Thus, the search
of novel venom inhibitors is therefore relevant, being natural
or synthetic, in order to complement the current serum
therapy and to neutralize the remaining damages of snake
envenomation.
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Hypericum brasiliense is an annual cycle plant, recurrent
in the southern and southeastern Brazil, known by the com-
mon names of “milfurada”, “milfacadas,” and “alecrim bravo”
[8, 9]. H. brasiliense extract has shown anti-inflammatory
and analgesic [10] activities, with contradictory signs on the
CNS [11] and protection of mice against lethality of Bothrops
jararaca venom [12].
The present work demonstrates the ability of Hypericum
brasiliense standardized extract and quercetin to counteract
neurodegenerative insults induced by Cdt venom in brain
and muscles preparations. In addition, it is shown that the
major neurotoxic components of the Crotalus durissus ter-
rificus venom, crotoxin and crotamine, also had their effects
prevented in the neuromuscular paralysis at mouse nerve-
muscle preparations.
2. Experimental
2.1. Reagents and Venom. All chemicals and reagents used
were of the highest purity and were obtained from Sigma,
Aldrich,Merck or BioRad.Crotalus durissus terrificus venom,
crotamine and crotoxin were donated by Dr. S. Marangoni
(UNICAMP) and quercetin by Dr. L. Rocha (UFF).
2.2. Animals. Adult Swiss white mice (28–35 g) from both
sexes were supplied by the Multidisciplinary Center for
Biological Investigation (CEMIB) at UNICAMP and by the
animal facility from Universidade Federal de Santa Maria
(UFSM). The animals were housed at 25∘C with access ad
libitum to food and water. These studies have been done in
accordance with the guidelines of the Brazilian College for
Animal Experimentation (COBEA).
2.3. Plant Material. Hypericum brasiliense leaves were col-
lected in the city of Nova Friburgo, RJ, Brazil, in 2001.
A voucher specimen (n∘19980) has been deposited at the
herbarium of the Museu Nacional, Universidade Federal do
Rio de Janeiro, Brazil.
2.4. Chemical Analysis. The preparation of H. brasiliense
EtOH extract (HBE) and detection of its chemical compo-
sition were carried out as described elsewhere [13]. Briefly,
the chemical analysis was performed with a Liquid Chro-
matograph (GBC Scientific Equipment LLC, Hampshire, IL,
USA), equipped with a Nucleosil MN 120-5 C
18
silica column
(Macherey-Nagel Inc., Bethelehem, PA, USA). The elution
was made at room temperature using a linear gradient from
10–60% of acetonitrile in trifluoroacetic acid (0.05% v/v) at a
flow rate of 1.0mL/min in 30 minutes. Peaks were monitored
at 254 nm in order to quantify the flavonoid quercetin.
2.5. Hippocampal Slices Preparation. Mice were decapitated,
the brains removed immediately, and the hippocampus dis-
sected on ice and humidified in cold HEPES-saline buffer
gassed with O
2
(124mm NaCl, 4mM KCl, 1.2mM MgSO
4
,
12mM glucose, 1mM CaCl
2
, and 25mM HEPES pH 7.4).
Hippocampal slices were obtained according to Vinade´ &
Rodnight [14], briefly: a Mcilwain tissue chopper was used
to obtain the slices (0.4mm) that were separated and prein-
cubated at 37∘C for 30min in microwell plates filled with
HEPES saline (200𝜇L/slice). Subsequently, fresh medium
was replaced (200𝜇L/slice) for control condition and treat-
ments with Cdt (1, 5 and 10 𝜇g/mL), HBE (100 𝜇g/mL),
HBE + Cdt, quercetin (10𝜇g/mL), and quercetin + Cdt and
incubated for 1 hour (37∘C).
2.6. Hippocampal Slices Viability. Immediately after incuba-
tion with treatments, slices were assayed for a 3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test
(0.05% in HEPES-saline) for 30min (37∘C) [15]. The MTT
is converted into a purple formazan product after cleavage
of the tetrazolium ring by mitochondrial dehydrogenases.
Formazan was dissolved by the addition of DMSO, resulting
in a colored compound whose optical density (𝜆 = 550 nm)
was measured in an ELISA reader equipment [16].
2.7. Phrenic Nerve-Diaphragm Preparation. Whole dia-
phragms along with the phrenic nerves were removed from
mice killed by carbon dioxide (CO
2
) and exsanguinated. Both
hemidiaphragms were mounted essentially as described for
dal Belo et al. [17]. The preparations were suspended under
a constant tension of 5 g in a 5mL organ bath containing
aerated (95%O
2
–5%CO
2
) Tyrode solution (pH 7.4, 37∘C)
of the following composition (mM): NaCl 137, KCl 2.70,
CaCl
2
1.80, MgCl
2
0.490, NaH
2
PO
4
0.420, NaHCO
3
11.9, and
glucose 11.1. Supramaximal stimuli (0.1 Hz, 0.2ms) delivered
by a Grass S4 electronic stimulator (Grass Instrument Co.,
Quincy, MA, USA) were applied through electrodes placed
around the motor nerve, corresponding to an indirect stimu-
lation.
2.8. Statistical Analysis. The results were expressed as the
mean ± SEM and were compared statistically using ANOVA
for repeated measures. A 𝑃 value < 0.05 indicated signifi-
cance.
3. Results
HBE was shown to be rich in flavonoids derivatives such as
kaempferol, quercetin, and quercetin glycosides (quercitrin,
isoquercitrin, guaijaverin, and hyperoside) [13]. The selective
extraction of polyphenol compounds in HBE resulted, after
hydrolysis, in not less than 6,7% of total flavonoids, expressed
as quercetin. Incubation of mouse phrenic nerve-diaphragm
preparation (PND) with Tyrode solution did not induce
alterations in basal muscle twitch tension during 120min
recordings (𝑛 = 5, Figure 1).WhenCrotalus durissus terrificus
venom (Cdt, 10 𝜇g/mL) was added to (PND) preparation
there was an increase of 160% in the muscle twitch tension
followed by an irreversible and complete neuromuscular
blockade after 70min (𝑛 = 5, Figure 1). Incubation of
PND preparation with HBE (10 and 100𝜇g/mL) produced
no alteration in the amplitude of muscle twitch tension (𝑛 =
5), during 120min observation. However, when prepara-
tions were assayed with a mixture of HBE (50 𝜇g/mL and
100 𝜇g/mL) and Cdt venom (10 𝜇g/mL) previously incubated
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Figure 1: Neutralizing activity of H. brasiliense ethanolic plant extract (HBE) against Crotalic venom, crotoxin and crotamine at mouse
phrenic nerve-diaphragm preparations. Panel (a) shows the inhibitory effect of HBE (10 and 100 𝜇g/mL) against C. d. terrificus venom
(10𝜇g/mL), crotoxin and crotamine. In Panel (b) effect of Quercetin (10 and 100𝜇g/mL) against Cdt (10𝜇g/mL), crotoxin (1 𝜇g/mL), and
crotamine (1 𝜇g/mL). When HBE was applied alone in the organ-bath no alteration in the twitch-tension was observed. On both graphs
control Tyrode solution lines show no alteration of normal nerve-muscle activity. The points on the graphs represent the mean ± S.E.M. of
five experiments. On (b) note that quercetinmimicked the protective effect induced byHBE.HBE:Hypericum brasiliense standardized extract
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𝑃 < 0.05 compared to control Tyrode.
during 30min at 37∘C, the characteristic neuromuscular
blockade was prevented in 75% with the highest concen-
tration of the extract (Figure 1(a), 𝑛 = 5, 𝑃 < 0.05).
The assay of the myotoxin crotamine (1 𝜇g/mL) alone at
PND preparations induced a significative increase of muscle
twitch tension (∼150%), that was maximum at 30min (𝑃 <
0.05, 𝑛 = 6, Figure 1(b)). On the contrary, the addition
of the PLA
2
neurotoxin crotoxin isolated (1𝜇g/mL) at PND
preparations caused a progressive and irreversible neuromus-
cular blockade during 120min recordings (𝑃 < 0.05, 𝑛 =
6). The assay of HBE (100𝜇g/mL) + crotamine (1 𝜇g/mL)
or crotoxin (1 𝜇g/mL), previously incubated for 30min at
37∘C, inhibited 100% of the facilitatory actions induced by
crotamine and 85% of the neuromuscular blockade caused by
crotoxin (1𝜇g/mL), respectively, in 120min recordings (𝑛 =
5,𝑃 < 0.05, data not shown).When quercetin (10𝜇g/mL)was
incubated alone, there was a maximum decrease of muscle
twitch tension of 20 ± 0.5% in 120min recordings, although
not significative (Figure 1(b), 𝑃 > 0.05 compared to the
control Tyrode). The addition of quercetin (10𝜇g/mL) with
crotamine (1𝜇g/mL) or crotoxin (1 𝜇g/mL) previously incu-
bated for 30min at 37∘Cshowed amore potent antineurotoxic
activity when compared to the HBE. This increased potency
of quercetin compared to HBE must be due to a higher
effective concentration of the flavonoid when compared to
the whole extract (∼7%). Quercetin was able to completely
inhibit the facilitatory actions of crotamine (1 𝜇g/mL) and
decreased in 80 ± 5% the neuromuscular blockade induced
by crotoxin (1 𝜇g/mL) (𝑛 = 5, 𝑃 < 0.05, Figure 1(b)).
The effect of HBE (100𝜇g/mL) or quercetin (10 𝜇g/mL)
alone was accessed at central nervous system (CNS) through
hippocampal slices. In this set of experiments the cell viability
was not modified after 1 h incubation with both vegetal
extract and the pure flavonoid. On the other hand, the incu-
bation of Cdt venom in doses of (1, 5, and 10 𝜇g/mL) signi-
ficantly decreased the cell viability (40 ± 3, 14 ± 1 and
28 ± 1%, 𝑛 = 3, 𝑃 < 0.05, resp.) (Figures 2(a) and
2(b)). The addition of HBE (100 𝜇g/mL) with Cdt (10𝜇g/mL)
to the slices produced a slight protection compared to the
control Cdt (𝑛 = 3, 𝑃 < 0.05) (Figure 2(a)). However, the
blend of quercetin (10𝜇g/mL) and Cdt (1𝜇g/mL or 5𝜇g/mL),
significantly inhibited the cell lysis showing a protection in
the order of 46±2% and 12±1%, 𝑛 = 4,𝑃 < 0.05, respectively
(Figure 2(b)). The results in hippocampal slices confirm the
HBE and quercetin potential role in the neuroprotection
against Cdt poisoning. Therefore, the difference in potency
between HBE and quercetin must also be related to the less
amount of the flavonoid in the extract.
4. Discussion
In this work we described for the first time the effectiveness
of theH. brasiliense extract (HBE) and its marked compound
quercetin, against the neuromuscular paralysis induced by
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Figure 2: Effects of Cdt on the viability of hippocampal slices. (a) Hippocampal slices were incubated with HBE (100𝜇g/mL) in the presence
or absence of Cdt (10𝜇g/mL) during 1 hour. (b) Hippocampal slices were incubated during 1 hour with Quercetin (10𝜇g/mL) in the presence
or absence of Cdt (1 and 5 𝜇g/mL). Cell viability was measured by MTT test. Values are expressed as % of control, which was defined as
untreated slices (values are means ± S.E.M., 𝑛 = 4). On (b) note that quercetin mimicked the HBE protective activity. HBE: Hypericum
brasiliense standardized extract∗∗ 𝑃 < 0.05 compared to control∗.
Crotalus durissus terrificus snake venom (Cdt), crotoxin, and
crotamine at mouse phrenic nerve-diaphragm preparations.
Also, the effectiveness of HBE and quercetin was validated, to
counteract the deleterious effects induced by C. d. terrificus
venom, on cell viability of mouse brain slices. Crotalus
venom induces neurotoxicity, coagulation disorders, systemic
myotoxicity, and acute renal failure [18], with possible addi-
tional heart and liver damage [19]. This venom is a mixture
of enzymes, toxins (crotoxin, crotamine, gyroxin, and con-
vulxin), and several other peptides [19]. The characteristic
pathophysiological pictures of neurotoxicity and systemic
myotoxicity associated with C. d. terrificus envenomation are
mainly related to the presence in the venom of crotoxin,
a neurotoxic PLA
2
heterodimeric complex, which causes
progressive paralysis, and in high concentrations myonecro-
sis [20, 21]. At nerve terminals, crotoxin induces triphasic
alterations in the mean quantal content of transmitter release
with a slow and progressive decrease of presynaptic release
of the neurotransmitter acetylcholine that results in complete
neuromuscular blockade [22, 23]. At mammal central ner-
vous system, the injection of Cdt venom induces seizures [5],
which is mainly associated with the presence of crotoxin [24].
At brain synaptosomes, crotoxin has also shown the ability
of inhibiting L-glutamate and gamma aminobutyric acid
(GABA) uptake [25]. Crotamine is the second major toxin in
the Cdt venom; it is a basic, low molecular weight myotoxin
devoid of PLA
2
activity [26], with a specific action on voltage-
sensitive sodiumchannels ofmuscles [27] and brain cells [28].
Flavonoids are plant secondary metabolites that embrace
a wealth of possibilities of hydrogen bonding arranged
around a relatively small carbon skeleton, capable of interact-
ing with molecular targets [29]. In the H. brasiliense extract,
the flavonoid quercetin and its derivatives were shown to
be the major secondary metabolites in the plant. Quercetin
and several of its glycosides are the most often encountered
flavonoids in anti-snake venom plants where Albizia lebbeck,
Achillea millefolium, Euphorbia hirta, Camellia sinensis, and
Casearia sylvestris are some examples. Flavonoids have been
reported as snake venom phospholipase A
2
inhibitors [30].
Recent studies revealed that the treatment of the snake
venom PLA
2
isoform from Crotalus durissus cascavella snake
venom with the flavonoid quercetin produced a decrease in
the pharmacological activity of the neurotoxin by inducing
alterations in the secondary but not in tertiary structure
composition of the molecule [31]. As discussed above,
flavonoids have the ability of binding to biological polymers
(e.g., enzyme inhibiting activities). Therefore, snake PLA
2
catalyzed the production of lysophospholipids and fatty acids
that are involved in membrane damage [21]. We suggest that,
in the casewhere biological activity is enzyme-dependent, the
HBE antineurotoxic activity would involve the inactivation
of PLA
2
activity by quercetin. However, the possibility that
the HBE acts through a mechanistic intervention rather than
an in vitro direct physical interaction with the venom is also
a reasonable idea. This is likely to be the mode of action
of many polyphenolic compounds found in plant extracts,
which probably explains many of the “protective” effects of
plant extracts when they are preincubated with venom before
administration to the biological assay [32, 33].
Flavonoids derived from plants or tea extracts also affect
acetylcholine release, muscle contraction, or neuromuscu-
lar junction activity [34]. In this regard, the muscle-type
nicotinic acetylcholine receptor consists of 𝛼1𝛽1𝜀, in adult
tissue [35]. It was found that quercetin inhibits the muscle
type nicotinic acetylcholine receptor, by binding on the 𝛾 or
𝜀 subunities, which is a characteristic of a noncompetitive
inhibitor [36]. Crotoxin also stabilizes the postsynapticmem-
brane of Torpedo marmorata by binding in non-ACh biding
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sites [37]. Hence, these similarities in terms of binding sites
would strengthen the hypothesis of a site-direct antagonism
between quercetin and crotoxin at nerve terminals. In addi-
tion, quercetin actively participates in intracellular signaling,
inhibiting phosphatidylinositol-3 kinase, protein kinase C,
xanthine oxidase, and NADPH diaphorase [34]. In massive
cellular insults like ischemia, involving metabolic failure, loss
of Ca2+ homeostasis, and excitotoxicity, scavenger activity or
one-target antioxidant mechanisms (NMDA receptor block-
ers, chain-breaking vitamin E, or pure scavenger molecules
such as boldine) may fail to protect cells from free radical
damage. Current explanation for the neuroprotective effect of
quercetin is its antioxidant capacity and its ability to scavenge
free radicals [34]. At moment there is no evidence that snake
venoms induce cellular insults to increase free radicals in
nerve terminals. However, the actions of Cdt venom on cell
viability of brain slices is likely to be devoid to the presence
of crotoxin and crotamine that ultimately account for the
increase of excitatory neurotransmitters [22], resulting in
excitotoxicity [38]. The decrease in neurotransmitter uptake
by crotoxin is calcium independent [25], and quercetin
potentiates neuronal excitability by increasing neuronal firing
rates [39]. Ultimately, excitotoxicity is a result of synaptic dys-
function processes, which involves the excessive glutamate
receptor activation and neuronal degeneration [38]. Based on
the above considerations we suggest that the mechanism of
the benefit of quercetin on snake venom-induced neuronal
cellular death is complex and beyond the inhibition of
presynaptic activity of snake PLA
2
, and structural modifi-
cations, which may affect neurotransmitter uptake, involve
the maintenance of neuronal mitochondrial transmembrane
electric potential which would decrease the overstimulation
of glutamate receptors [34]. However, in the case of cro-
tamine, a direct inhibition of voltage-gated sodium channels
by quercetin seems to be a coherent explanation [40].
Further investigation on Hypericum brasiliense isolated
compounds will strengthen the understanding of its antio-
phidian activity. Preclinical assays, including safety assess-
ment protocols, could also open the way towards therapeutic
use of Hypericum brasiliense especially when neurotoxic
venoms are involved.
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